Diffusion Tensor Imaging News Today

Longeveron Inc. announced additional new clinical and biomarker results from its Phase 2a CLEAR MIND trial of its investigational product Lomecel-B? for the treatment of mild Alzheimer?s disease. The...

Invisible wounds like blast exposures and TBIs reshape soldiers' lives. Dive into the science, stigma, and hopeful advances in treatment.

3T MRI, Fetal Imaging USG and Kranium at FATHER MULLER Mangaluru: The Father Muller Medical College Hospital in its drive for GEN NEXT care for its

ASD, a complex neurodevelopmental disorder, is known to be linked to altered brain development. However, precise markers that can accurately diagnose ASD at the individual level have been elusive.

TORONTO and TEL AVIV, Israel, June 22, 2023 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. ("NurExone" or the "Company") (TSXV: NRX) (FSE: J90) (NRX.V), is...

There's no body based indicators for psychiatric disorders unlike other diseases. BrainSightAI’s AI-enabled suite conducts brain mapping within an hour to enable neurosurgeons, psychiatrists and neurologists to offer greater precision in diagnosis for neurological and psychiatric disorders.

MIT neuroscientists discovered anatomical changes that occur in the white matter of visual-processing areas of the brain, in children who have congenital cataracts surgically removed.

Cancer Biomarkers Market study by "Data Bridge Market Research" provides details about the market dynamics affecting this market, Market scope, Market

Many patients who have had Lyme disease struggle with cognitive challenges, even after treatment. This new imaging study shows changes in white matter that might explain these symptoms.

District Court for the Southern District of New York provided victory for admissibility of diffusion tensor imaging. Defendant moved to preclude testimony of plaintiff’s expert witnesses, neuroradiologist Gregory J. Lawler. Testimony not based upon a reliable methodology.